Thomas Smith

Thomas Smith

Analyst-Equity at Leerink Partners LLC

Finance
Technology Services
Consumer Services

Profile

Mr. Thomas J.
Smith
is a Senior Managing Director of Immunology & Metabolism at Leerink Partners LLC.
He is also a Senior Research Analyst covering Immunology and Metabolism.
Prior to covering the Immunology and Metabolism sector, Mr. Smith was a key member of Leerink Partners’ Targeted Oncology team helping to deliver in-depth fundamental research to clients.
Prior to joining the firm in 2018, he was most recently a Vice President and Research Analyst at Morgan Stanley, covering leading and emerging biopharmaceutical companies across numerous therapeutic areas, including oncology, NASH, and lead coverage of women’s health companies.
Prior to that, he worked at FBR Capital Markets on the biotechnology team, responsible for coverage of large, mid-, and small cap companies.
Mr. Smith began his career at Bloomberg where he held roles of increasing responsibility, including coverage of the biotech and specialty pharmaceutical sectors for Bloomberg Intelligence.
He earned his B.S.
in Finance and Psychology from The College of New Jersey.

Thomas Smith active positions

CompaniesPositionStart
Analyst-Equity 2018-04-30
All active positions of Thomas Smith

Former positions of Thomas Smith

CompaniesPositionEnd
Analyst-Equity 2018-04-30
Analyst-Equity 2014-12-30
Corporate Officer/Principal 2014-04-29
Corporate Officer/Principal 2007-05-30
See the detail of Thomas Smith's experience

Training of Thomas Smith

The College of New Jersey Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas Smith's experience

Connections

99

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies5

Finance

Technology Services

Finance

Finance

Finance

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW